From the International Herald Tribune:
Novartis to buy Canadian drug maker
Novartis, Switzerland's largest drug company, said on Monday that it would acquire the closely held Canadian generic drug maker Sabex Holdings for $565 million in cash.

Sabex, based in Quebec, is a leading maker of injectable generic drugs and has annual sales of about $90 million. Novartis's Sandoz unit is the world's second-largest generic drug maker.